These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 15543335

  • 1. Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a).
    Lamanuzzi LB, Mtairag el M, Pepe G, Anglés-Cano E.
    Thromb Haemost; 2004 Nov; 92(5):1066-75. PubMed ID: 15543335
    [Abstract] [Full Text] [Related]

  • 2. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W, Gabel BR, Boffa MB, Walker JB, Hancock MA, Marcovina SM, Horrevoets AJ, Nesheim ME, Koschinsky ML.
    Biochemistry; 1997 Aug 26; 36(34):10353-63. PubMed ID: 9265615
    [Abstract] [Full Text] [Related]

  • 3. Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells.
    Ho-Tin-Noé B, Meilhac O, Rossignol P, Lijnen HR, Anglés-Cano E.
    Thromb Haemost; 2006 Jan 26; 95(1):142-50. PubMed ID: 16543973
    [Abstract] [Full Text] [Related]

  • 4. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments.
    Edelstein C, Italia JA, Scanu AM.
    J Biol Chem; 1997 Apr 25; 272(17):11079-87. PubMed ID: 9111002
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
    Liu L, Boffa MB, Koschinsky ML.
    PLoS One; 2013 Apr 25; 8(1):e52287. PubMed ID: 23326327
    [Abstract] [Full Text] [Related]

  • 6. Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation.
    Sangrar W, Bajzar L, Nesheim ME, Koschinsky ML.
    Biochemistry; 1995 Apr 18; 34(15):5151-7. PubMed ID: 7711034
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E, Rojas G.
    Biol Chem; 2002 Jan 18; 383(1):93-9. PubMed ID: 11928826
    [Abstract] [Full Text] [Related]

  • 8. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
    Anglés-Cano E, Hervio L, Rouy D, Fournier C, Chapman JM, Laplaud M, Koschinsky ML.
    Chem Phys Lipids; 1994 Jan 18; 67-68():369-80. PubMed ID: 8187237
    [Abstract] [Full Text] [Related]

  • 9. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z, Zhang PX, Wang P, Gurewich V, Shen HY, Liu JN.
    Thromb Res; 2002 Apr 15; 106(2):105-11. PubMed ID: 12182908
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
    Rouy D, Koschinsky ML, Fleury V, Chapman J, Anglés-Cano E.
    Biochemistry; 1992 Jul 14; 31(27):6333-9. PubMed ID: 1627572
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells.
    Romagnuolo R, DeMarco K, Scipione CA, Boffa MB, Koschinsky ML.
    Thromb Res; 2018 Sep 14; 169():1-7. PubMed ID: 29990619
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance.
    Hancock MA, Spencer CA, Koschinsky ML.
    Biochemistry; 2004 Sep 28; 43(38):12237-48. PubMed ID: 15379562
    [Abstract] [Full Text] [Related]

  • 15. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B, Rojas G, Vranckx R, Lijnen HR, Anglés-Cano E.
    FEBS J; 2005 Jul 28; 272(13):3387-400. PubMed ID: 15978044
    [Abstract] [Full Text] [Related]

  • 16. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH, Lee HJ, Lee EK, Yu HK, Lee TH, Yoon Y, Kim SJ, Kim JS.
    Biol Chem; 2011 Apr 28; 392(4):347-56. PubMed ID: 21194375
    [Abstract] [Full Text] [Related]

  • 17. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
    Rahman MN, Petrounevitch V, Jia Z, Koschinsky ML.
    Protein Eng; 2001 Jun 28; 14(6):427-38. PubMed ID: 11477223
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A structural assessment of the apo[a] protein of human lipoprotein[a].
    Guevara J, Knapp RD, Honda S, Northup SR, Morrisett JD.
    Proteins; 1992 Feb 28; 12(2):188-99. PubMed ID: 1318546
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation.
    Feric NT, Boffa MB, Johnston SM, Koschinsky ML.
    J Thromb Haemost; 2008 Dec 28; 6(12):2113-20. PubMed ID: 18983515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.